Northwire Canada EditionTuesday, August 18, 2026
Northwire
GRZ 6.55 +0.8% HMR 0.480 −4.0% IMR 0.150 −3.2% KNT 29.05 +2.2% CPL 0.240 +9.1% ANK 0.330 +0.0% RML 1.16 +0.0% MSG 0.235 +2.2% TRO 0.130 +4.0% HDRO 1.52 +4.8% LOD 0.425 +6.2% ELBM 0.790 −2.5% AG 27.18 +1.6% PAAS 66.78 +1.5% GGM 0.035 +0.0% NTH 0.152 −4.7% GRZ 6.55 +0.8% HMR 0.480 −4.0% IMR 0.150 −3.2% KNT 29.05 +2.2% CPL 0.240 +9.1% ANK 0.330 +0.0% RML 1.16 +0.0% MSG 0.235 +2.2% TRO 0.130 +4.0% HDRO 1.52 +4.8% LOD 0.425 +6.2% ELBM 0.790 −2.5% AG 27.18 +1.6% PAAS 66.78 +1.5% GGM 0.035 +0.0% NTH 0.152 −4.7%
Financings

First Phosphate arranges $15-million private placement

PHOS · Price

Executive Summary

  • First Phosphate Corp. announced a best‑efforts private placement of up to 25 million units at $0.60 per unit, targeting gross proceeds of up to $15 million.
  • Each unit consists of one common share and one common share purchase warrant (exercise price $0.90, 36‑month term).
  • Net proceeds are earmarked for the feasibility study and permitting of the Begin‑Lamarche flagship property, downstream infrastructure development, acquisitions, and general corporate purposes; closing is expected on Oct. 10, 2025.

Key Details

  • Placement Structure: Up to 25 million units; each unit = 1 common share + 1 warrant.
  • Pricing: $0.60 per unit → up to $15 M gross proceeds.
  • Warrant Terms: Exercise price $0.90 per share, exercisable for 36 months from closing.
  • Lead Agent/Bookrunner: Integrity Capital Group Inc. (best‑efforts basis).
  • Commission & Broker Warrants:
  • Cash commission to Integrity = 8 % of gross proceeds (reduced to 2 % on certain President’s List purchases).
  • Non‑transferable broker warrants issued to Integrity equal to 8 % of units sold (also reduced to 2 % on certain President’s List purchases); each warrant exercisable at $0.90 per share for 36 months, subject to a hold period of four months and one day post‑closing.
  • Regulatory Framework: Offered under NI 45‑106 prospectus exemptions; units sold to Canadian residents via listed issuer financing exemption; may also be offered in the U.S. and offshore jurisdictions where lawful.
  • Use of Proceeds:
  • Completion of feasibility study & permitting for Begin‑Lamarche property.
  • Development of downstream infrastructure.
  • Potential acquisitions.
  • General corporate purposes.
  • Closing Date: Scheduled for Oct. 10, 2025 (or other dates as determined).

Notable Quotes

(No direct quotes provided in the release.)

Read the original news release →

More from First Phosphate Corp